BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7588026)

  • 1. [Phenprocoumon-induced necrotizing hepatitis].
    Ehrenforth S; Scharrer I; Herrmann G
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1529-30. PubMed ID: 7588026
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenprocoumon-associated necrotizing hepatitis].
    Weber T; Hinterreiter M; Knoflach P
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1060. PubMed ID: 11565062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute necrotizing hepatitis: an unusual side effect of oral anticoagulants].
    Capoferri M; Realini S; Balestra B
    Praxis (Bern 1994); 2000 May; 89(21):929-32. PubMed ID: 10859983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenprocoumon-induced necrotizing hepatitis].
    Schneider AR; Hartmann D; Arnold JC; Bohrer MH; Riemann JF
    Dtsch Med Wochenschr; 2001 Apr; 126(16):457-9. PubMed ID: 11360450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenprocoumon-induced cholestatic hepatitis].
    Woolley S; Burger HR; Zellweger U
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1507-10. PubMed ID: 7588020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorder.
    Bux-Gewehr I; Zotz RB; Scharf RE
    Thromb Haemost; 2000 May; 83(5):799-800. PubMed ID: 10823289
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure.
    Schimanski CC; Burg J; Möhler M; Höhler T; Kanzler S; Otto G; Galle PR; Lohse AW
    J Hepatol; 2004 Jul; 41(1):67-74. PubMed ID: 15246210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenprocoumon-induced liver failure].
    Cordes A; Vogt W; Dahm HH; Maier KP
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1884-6. PubMed ID: 12970822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrent hepatitis in oral anticoagulation: coumarin-induced hepatitis].
    Kremer Hovinga JA; Wuillemin WA
    Ther Umsch; 1999 Sep; 56(9):513-5. PubMed ID: 10517122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis.
    Hinrichsen H; Lüttges J; Klöppel G; Fölsch UR; Schmidt WE
    Scand J Gastroenterol; 2001 Jul; 36(7):780-3. PubMed ID: 11444480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring)].
    Ciorciaro C; Hartmann K; Stoller R; Kuhn M
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2109-13. PubMed ID: 8999497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with activated protein C resistance due to factor V R506Q mutation.
    Wuillemin WA; Zenhäusern R; Bernhard MC; Lämmle B
    Am J Med; 1997 Nov; 103(5):437-9. PubMed ID: 9375713
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease.
    Klein R
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1195-201. PubMed ID: 19641912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic hepatitis related to the oral anticoagulant phenprocoumon.
    Hautekeete M; Holvoet J; Hubens H
    Gastroenterol Clin Biol; 1995 Feb; 19(2):223-4. PubMed ID: 7750715
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis.
    de Man RA; Wilson JH; Schalm SW; ten Kate FJ; van Leer E
    J Hepatol; 1990 Nov; 11(3):318-21. PubMed ID: 1963177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenprocoumon-induced liver failure.
    de Man RA
    Neth J Med; 1993 Aug; 43(1-2):91. PubMed ID: 8232701
    [No Abstract]   [Full Text] [Related]  

  • 17. Coumarin-associated hepatitis. Report of two cases.
    Slagboom G; Loeliger EA
    Arch Intern Med; 1980 Aug; 140(8):1028-9. PubMed ID: 7396606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver damage in a patient treated with a vitamin K antagonist, a statin and an ACE inhibitor].
    Bruggisser M; Terraciano L; Rätz Bravo A; Haschke M
    Praxis (Bern 1994); 2010 Oct; 99(21):1259-65. PubMed ID: 20960395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver damage induced by coumarin anticoagulants.
    Ehrenforth S; Schenk JF; Scharrer I
    Semin Thromb Hemost; 1999; 25(1):79-83. PubMed ID: 10327225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases.
    Neef M; Kerekes Z; Fischer HP; Sauerbruch T; Spengler U
    Digestion; 2003; 67(1-2):100-4. PubMed ID: 12743448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.